Wire Stories
-
11BW LPG Limited – Financial Results for Q3 2025
SINGAPORE–(BUSINESS WIRE)–BW LPG Limited: Highlights Q3 2025 Q3 2025 profit: Q3 2025 profit attributable to equity holders of the Company ended at...
-
11
BW LPG Limited – Key Information Relating to the Cash Dividend for Q3 2025
SINGAPORE–(BUSINESS WIRE)–BW LPG Limited (“BW LPG” or the “Company”, OSE ticker code: “BWLPG.OL”, NYSE ticker code “BWLP”) provides the following key information...
-
12
TotalEnergies, TES, Osaka Gas, Toho Gas and ITOCHU Partner Up to Develop the Live Oak Project for e-NG Production in Nebraska
PARIS–(BUSINESS WIRE)–TotalEnergies (Paris:TTE) (LSE:TTE) (NYSE:TTE), TES, Osaka Gas, Toho Gas, and ITOCHU have signed a Joint Development and Operating Agreement, granting the...
-
13
Tech Leaders Brace for 2026: Security, Connectivity and Data Sovereignty at Stake, According to Expereo
LONDON–(BUSINESS WIRE)–2025 has been a transformative year for global technology. Rapid deployment of advanced connectivity infrastructure, AI-driven solutions and increased focus on...
-
11
P.I. Works Drives Stronger Network Results for Beeline Uzbekistan
ISTANBUL–(BUSINESS WIRE)–P.I. Works celebrates the success of its long-time client Beeline Uzbekistan, recognized by independent global analytics firms Opensignal and Ookla for...
-
13
Hanshow Achieves SOC 2 Type II and SOC 3 Certifications, Elevating Data Security Standards for Global Retailers
SHANGHAI–(BUSINESS WIRE)–Hanshow, a global leader in digital retail solutions, announced that its All-Star digital solution has earned SOC 2 Type II and...
-
13
Netcracker Completes Revenue Management Modernization for SLT-MOBITEL
Leading Asian Operator Leverages Advanced Features of Netcracker Digital BSS Along With Multi-Year Support Services for Enterprise and Retail Lines of Business...
-
12
Aurigene Oncology Limited Announces Encouraging Initial Data From 1st Two Cohorts of Phase 1 Study of AUR112, an Oral Small Molecule Inhibitor of MALT1, in Relapsed/Refractory Lymphoid Malignancies
BANGALORE, India–(BUSINESS WIRE)–#AurigeneOncology–Aurigene Oncology Limited, a clinical-stage biopharmaceutical company developing novel therapies in oncology, today announced initial clinical results from 1st two...
-
11
Development Bank of Japan and Chiyoda Invest in Heirloom
Strategic investments position Heirloom for participation in Japan’s emerging carbon market BRISBANE, Calif.–(BUSINESS WIRE)–Heirloom, America’s leading Direct Air Capture (DAC) technology provider,...
-
12
AdvanCell Initiates Phase 2 Expansion Trial of ADVC001, a Novel Targeted Alpha Therapy for Prostate Cancer
Clinical development of 212Pb-ADVC001 (ADVC001) is advancing rapidly with encouraging Phase 1b data presented at ESMO 2025 The Phase 2 expansion will...
